Remove 2025 Remove Hospitality Remove Neurotransmitters and mental health
article thumbnail

Spravato Approved for Treatment-Resistant Depression

ADDitude

February 25, 2025 Spravato, the esketamine nasal spray approved in 2019 for use alongside oral antidepressants for treatment-resistant depression, has been approved by the U.S. Esketamine is a form of the dissociative agent ketamine , commonly used as an anesthetic; it works by targeting the neurotransmitter glutamate.

article thumbnail

It's Okay to Need Medication for Mental Health Treatment

Zencare

Published on January 22, 2025 by Zencare Team. There are 298 mental health conditions currently recognized in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition-TR, which is the standard reference for clinical practice among trained, licensed mental health professionals, in the US.